EUVIMEDEUVIMED entdecken
Fallbericht

Treatment of multiple myeloma with manifestations of light chain deposition disease; complete remission with minimal residual disease negativity following treatment with daratumumab, dexamethasone, and lenalidomide – a case report and a review of the literature

Zdeněk Adam, Jan Svojanoský, Iva Svobodová, Aleš Tkadlec, Marek Borský, Marta Krejčí, Martin Štork, Ivanna Boichuk, Zdeněk Král, Luděk Pour

Transfuze a hematologie dnes · 10.03.2026 · 32 (1)

DOI: 10.48095/cctahd202609 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transfuze a hematologie dnes, online erschienen am 06.03.2026. Verfasst von Zdeněk Adam und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Adam, Z., Svojanoský, J., Svobodová, I., Tkadlec, A., Borský, M., Krejčí, M., Štork, M., Boichuk, I., Král, Z., & Pour, L. (2026). Treatment of multiple myeloma with manifestations of light chain deposition disease; complete remission with minimal residual disease negativity following treatment with daratumumab, dexamethasone, and lenalidomide – a case report and a review of the literature. Transfuze a hematologie dnes, 32(1). https://doi.org/10.48095/cctahd202609

Vancouver

Adam Z, Svojanoský J, Svobodová I, Tkadlec A, Borský M, Krejčí M, et al. Treatment of multiple myeloma with manifestations of light chain deposition disease; complete remission with minimal residual disease negativity following treatment with daratumumab, dexamethasone, and lenalidomide – a case report and a review of the literature. Transfuze a hematologie dnes. 2026;32(1). doi:10.48095/cctahd202609

BibTeX
@article{Adam2026,
  author = {Adam, Zdeněk and Svojanoský, Jan and Svobodová, Iva and Tkadlec, Aleš and Borský, Marek and Krejčí, Marta and Štork, Martin and Boichuk, Ivanna and Král, Zdeněk and Pour, Luděk},
  title = {Treatment of multiple myeloma with manifestations of light chain deposition disease; complete remission with minimal residual disease negativity following treatment with daratumumab, dexamethasone, and lenalidomide – a case report and a review of the literature},
  journal = {Transfuze a hematologie dnes},
  year = {2026},
  volume = {32},
  number = {1},
  doi = {10.48095/cctahd202609}
}
Kostenlos starten →